# EnerSyn Global Inc.: overview

ESYN · Nasdaq · CIK 1897245 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/esyn.md) · [Financials](/companies/esyn/financials.md) · [Filings](/companies/esyn/filings.md) · [Insiders](/companies/esyn/insiders.md)

Latest reported revenue: [$64.2k](/filings/0001493152-26-035475.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 30, 2026 (XBRL us-gaap:Revenues, accession 0001493152-26-035475).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [346](/filings/0001493152-25-018846.md) | [287 d](/filings/0001493152-26-012738.md) | [295](/filings/0001493152-26-022793.md) | [310](/filings/0001493152-26-035475.md) | [207](/filings/0001493152-25-018846.md) | [54.6 d](/filings/0001493152-26-012738.md) | [64.2](/filings/0001493152-26-022793.md) | [64.2](/filings/0001493152-26-035475.md) |
| Gross margin | % | [46.3%](/filings/0001493152-25-018846.md) | [39.6% d](/filings/0001493152-26-012738.md) | [50.0%](/filings/0001493152-26-022793.md) | [14.2%](/filings/0001493152-26-035475.md) | [59.8%](/filings/0001493152-25-018846.md) | [72.7% d](/filings/0001493152-26-012738.md) | [73.7%](/filings/0001493152-26-022793.md) | [31.7%](/filings/0001493152-26-035475.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [(158.7%)](/filings/0001493152-25-018846.md) | [(166.1%) d](/filings/0001493152-26-012738.md) | [(191.4%)](/filings/0001493152-26-022793.md) | [26.9%](/filings/0001493152-26-035475.md) | [(140.7%)](/filings/0001493152-25-018846.md) | [(3564.9%) d](/filings/0001493152-26-012738.md) | [(975.4%)](/filings/0001493152-26-022793.md) | [330.2%](/filings/0001493152-26-035475.md) |
| Diluted EPS | $ per share | not reported | not reported | [(0.09)](/filings/0001493152-26-022793.md) | [0.01](/filings/0001493152-26-035475.md) | not reported | not reported | [(0.08)](/filings/0001493152-26-022793.md) | [0.03](/filings/0001493152-26-035475.md) |
| Free cash flow | $k | [(277) d](/filings/0001493152-25-018846.md) | [(415) d](/filings/0001493152-26-012738.md) | not reported | not reported | [(218) d](/filings/0001493152-25-018846.md) | [(1,022) d](/filings/0001493152-26-012738.md) | [(193)](/filings/0001493152-26-022793.md) | [478 d](/filings/0001493152-26-035475.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-11-30) | FY2023 (2023-11-30) | FY (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | [1.2](/filings/0001641172-25-001707.md) | [1,254](/filings/0001493152-26-012738.md) | [867](/filings/0001493152-26-012738.md) |
| Gross margin | % | not reported | not reported | [41866.0%](/filings/0001641172-25-001707.md) | [48.0%](/filings/0001493152-26-012738.md) | [53.0%](/filings/0001493152-26-012738.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | [(91257.8%)](/filings/0001641172-25-001707.md) | [(219.4%)](/filings/0001493152-26-012738.md) | [(303.4%)](/filings/0001493152-26-012738.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | [(0.76)](/filings/0001493152-26-012738.md) | [(0.40)](/filings/0001493152-26-012738.md) |
| Free cash flow | $k | not reported | not reported | [(2,615)](/filings/0001641172-25-001707.md) | [(1,850)](/filings/0001493152-26-012738.md) | [(1,770)](/filings/0001493152-26-012738.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/esyn/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-06-08 | [Chan Heng Fai Ambrose](/insiders/1261725.md) | Chief Executive Officer, Director, Officer, 10% owner | Purchase (P) | 250,000 | $2.00 | $500.0k | [Form 4](/filings/0001493152-26-027990.md) |
| 2026-03-30 | [Chan Heng Fai Ambrose](/insiders/1261725.md) | Chief Executive Officer, Director, Officer, 10% owner | Sale (S) | 100,390 | $0.983 | $98.7k | [Form 4](/filings/0001493152-26-014753.md) |
| 2024-12-24 | [Chan Heng Fai Ambrose](/insiders/1261725.md) | Director, 10% owner | Purchase (P) | 1,300,000 | $0.45 | $585.0k | [Form 4](/filings/0001493152-24-052151.md) |
| 2024-11-25 | [Chan Heng Fai Ambrose](/insiders/1261725.md) | Director, 10% owner | Purchase (P) | 4,411,764 | $0.68 | $3.0m | [Form 4](/filings/0001493152-24-047868.md) |
| 2024-09-24 | [Chan Heng Fai Ambrose](/insiders/1261725.md) | Chief Executive Officer, Director, Officer, 10% owner | Purchase (P) | 476,190 | $0.63 | $300.0k | [Form 4](/filings/0001493152-24-038411.md) |
| 2024-09-24 | [Chan Heng Fai Ambrose](/insiders/1261725.md) | Chief Executive Officer, Director, Officer, 10% owner | Purchase (P) | 5,558,347 | $0.63 | $3.5m | [Form 4](/filings/0001493152-24-038411.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $44.7k | 31,455 |  | New +31,455 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $30.6k | 21,539 |  | Reduced −614 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $25.2k | 17,751 |  | Unchanged |
| [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $4.6k | 3,241 |  | Reduced −19 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $453 | 319 |  | Reduced −125 |
| [Clear Street Group Inc.](/funds/1881567.md) | 2026-06-30 | $28 | 20 |  | Unchanged |
| [Virtu Financial LLC](/funds/1533964.md) | 2026-06-30 | $15 | 10,580 |  | New +10,580 |
| [CITIGROUP INC](/funds/831001.md) | 2026-06-30 | $13 | 9 |  | Reduced −1,735 |

## Recent filings

[All 253 filings](/companies/esyn/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 21:51 ET | [SCHEDULE 13D/A](/filings/0001493152-26-049326.md) | Ownership report, active investor, amended | 0001493152-26-049326 |
| 2026-10-27 | 16:15 ET | [DEF 14A](/filings/0001493152-26-048698.md) | Proxy statement, period 2026-10-27 | 0001493152-26-048698 |
| 2026-09-18 | 17:24 ET | [8-K](/filings/0001493152-26-043411.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-043411 |
| 2026-09-11 | 09:21 ET | [8-K](/filings/0001493152-26-042315.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-042315 |
| 2026-09-01 | 17:28 ET | [8-K](/filings/0001493152-26-041064.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-041064 |
| 2026-08-17 | 17:12 ET | [SCHEDULE 13D](/filings/0001493152-26-038794.md) | Ownership report, active investor | 0001493152-26-038794 |
| 2026-08-11 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001493152-26-037149.md) | Ownership report, active investor, amended | 0001493152-26-037149 |
| 2026-08-10 | 16:45 ET | [8-K](/filings/0001493152-26-036887.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-036887 |
| 2026-08-07 | 09:28 ET | [SCHEDULE 13D/A](/filings/0001493152-26-036495.md) | Ownership report, active investor, amended | 0001493152-26-036495 |
| 2026-07-30 | 16:30 ET | [10-Q](/filings/0001493152-26-035475.md) | Quarterly report, period 2026-06-30 | 0001493152-26-035475 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-012738.md), filed Mar 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/13b992cf-0e0f-4c2b-a2c2-d8f656e38c1e)

## About the filer

- CIK: 1897245
- Tickers: ESYN
- Exchange: Nasdaq
- SIC code: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
- State of incorporation: NV
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 21:53 ET. No prices; not investment advice.